Tian, Xixi, et al. “Effect of Apatinib Mesylate on Clinical Remission Rate and Adverse Reactions in Patients With Advanced Primary Hepatocellular Carcinoma”. International Journal of Biology and Life Sciences, vol. 5, no. 1, Feb. 2024, pp. 13-16, https://doi.org/10.54097/t3s4wp88.